Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

The Latest Microsoft Hack Exposes the Need for this Security Opportunity

(Image via GlobeX Data Ltd.) Many around the world are still recovering after a massive cyber-attack on Microsoft Corp.’s (NASDAQ: MSFT) widely used business email software that evolved into a full global cybersecurity crisis. The hacking ...
Jonathon Brown | April 19, 2021 |

Sangamo Shares Trade 30% Higher on Q4 Earnings and Biogen Collaboration

Sangamo Therapeutics shares traded higher after the company reported Q4/19 and FY/19 earnings and advised that it signed a global collaboration agreement with Biogen to develop gene regulation therapies for Alzheimer's, Parkinson's, neuromuscular and neurological diseases. ...
Streetwise Reports | March 2, 2020 |

MyoKardia Shares Get a Jolt from Positive Phase 3 HCM Clinical Trial Results

Shares of MyoKardia traded 60% higher, setting a new 52-week high price, after the company reported that it met all primary and secondary endpoints in the Phase 3 EXPLORER study of mavacamten in treatment of obstructive hypertrophic cardiomyopathy. Clinical-...
Streetwise Reports | May 12, 2020 |

Small-Cap Pharma Fast-Tracking Repurposed Drug for Covid-19

Algernon Pharmaceuticals is quickly moving ahead with a multinational Phase 2b/3 trial for Ifenprodil. Algernon Pharmaceuticals Inc. (AGN:CSE; AGNPF:OTCQB; AGW:FSE) , a Canada-based clinical stage drug development company that focuses on drug repurposing, believes ...
Streetwise Reports | May 28, 2020 |

Investor Update from High Potential International Oil & Gas Exploration & Production Co.

When Stockhouse Editorial , last caught up with Calgary-based Bengal Energy Ltd. ( TSX.BNG , OTCMKTS: BNGLF , Forum ), our audience learned about an Australian-focused oil and gas exploration and production company with producing and prospective light oil-weighted on...
Dave Jackson | September 27, 2021 |

Is This A Gamechanger For The Lithium Industry?

2018 was a terrible year for commodities, but few sectors fared as badly as lithium. The crucial battery metal, also known as " White petroleum ", struggled through a 50 percent price correction as supply soared and demand fears spread like wildfire. But it isn't time ...
Charles Kennedy | April 29, 2019 |